Skip to main content

Table 4 Multivariate analysis of the survival of IPSS-R lower-risk subjects with respect to micro-megakaryocytes

From: A systematic classification of megakaryocytic dysplasia and its impact on prognosis for patients with myelodysplastic syndromes

  HR 95 % CI P value
Age (year)    0.024
 ≥60 1.856 1.086–3.171  
 <60* 1.0   
Gender    0.185
 IPSS-R    0.026
 Very-low 0 0–6.17E272  
 Low 0.478 0.280–0.816  
 Intermediate* 1.0   
Micro-megakaryocytes (%)    <0.01
 ≥25 2.806 1.509–5.218  
 <25* 1.0   
  1. * The reference